Bifurcated stent and method for the manufacture and delivery of same
Patent Information
- Application Number
- MYPI1997001911
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 1996-05-03
- Filing Date
- 1997-05-02
- Publication Date
- 1997-11-03
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Conventional mono-tubular stents are inadequate for bifurcated body passageways, leading to increased risks during placement, potential blockage of side branches, and inability to treat bifurcation lesions effectively without resorting to surgery.
A bifurcated stent with a tubular wall having a porous surface, designed to expand from a contracted to an expanded position, is developed, allowing for accurate placement in bifurcated body passageways, reducing stress on central walls, and enabling treatment of bifurcation lesions without compromising side branches.
The expandable bifurcated stent effectively maintains patency in bifurcated body passageways, reduces procedural complications, and allows for the treatment of bifurcation lesions without subjecting central walls to undue stress or blocking side branches.
Abstract
Description
BIFURCATED SfKNT AND METHOD fOU -ffflfMANUFACTURE AND DELIVERY OF SAMF.TECHNICAL FIELDThe present invention relates to a bifurcated stent and to a; method forthe manufacture and delivery of a bifurcated stent.BACKGROUND ARTStents are generally known. Indeed, the term "stent" has been usedinterchangeably with terms such as "intraluminal vascular igraft" and"expansible prosthesis". As used throughout this specification the term "stent"is intended to have a broad meaning and encompasses any expandable prostheticdevice for implantation in a body passageway (e.g. a lumen or artery).In the past six to eight years, die use of stents has attracted an increasingamount of attention due the potential of these devices to be used1, in certaincases, as an alternative to surgery. Generally, a stent is used to i obtain andmaintain the patency of the body passageway while maintaining the integrity ofthe passageway. As used in this specification, the term "body passageway" isintended to have a broad meaning and encompasses any duct (e.g: natural oriatrogenic) within the human body and can include a member selected from thegroup comprising: blood vessels, respiratory ducts, gastrointestinal ducts and the like.Initial stents were self-expanding, spring-like devices which wereinsetted in the body passageway in a contracted state. When released, the stentwould automatically expand and increase to a final diameter dependent on thesize of the stent and the elasticity of the body passageway. Such stents areknown in the art as the Wallstent™.The self-expanding stents were found by some investigators to bedeficient since, when deployed, they could place undue, permanent stress on thewalls of the body passageway. This lead to the development of various stentswhich were connollably expandable at the target body passageway so that onlysufficient force to maintain the patency of the body passageway Was applied inexpanding the stem.Generally, in these later systems, a stent, in association with a balloon,is delivered to the target area of the. body passageway by a catheter system.Once the stem has been properly located (the target area of the bodypassageway can be filled with a contrast medium to facilitate visualizationduring fluoroscopy), the balloon is expanded thereby expanding the stent, e.g.by plastic deformation of the stent structure, so that the latter is urged in placeagainst the body passageway. As indicated above, the amount of farce appliedis at least that necessary to maintain the patency of the body passagpwary. Atthis poini, the balloon is deflated and withdrawn within the catheter, andsubsequently removed. Ideally, the ste nt will remain in place and maintain thetarget area of the body passageway substantially free of blockage (ornarrowing).A stent which has gained some notoriety in the an is known as thePalmaz-Schatz™ Balloon Expandable Stem (hereinafter referred to as "thePalmaz-Schatz stent"). This stent is discussed in a number of patents includingUnited States patents 4,733,665, 4,739,762, 5,102,417 and 5,316,023, thecontents of each of which are hereby incorporated by reference.Another stent which has gained some notoriety in the art is known asGianturco-Roubin Flex-Stent™ (hereinafter referred to as "the Gianturco-Roubin stem"). This stent is discussed in a number of patents including UnitedStates patents 4,800,882, 4,907,336 and 5,041,126, the contents of each ofwhich are hereby incorporated by reference.Other types of stents are disclosed in the following patents: .United States patent 5,035,706 (Gianturco et al.),United States patent 5,037,392 (Hillstead),United States patent 5,147,385 (Beck et al.),United States patent 5.282,824 (Giantuico),Canadian patent 1,239,755 (Wallsten), andCanadian parent 1,245,527 (Gianturco ct al.),the contents of each of which are hereby incorporated by reference.All of the stents described in the above-identified patents share thecommon design of being mono-tubular and thus, are best suited to be deliveredand implanted in-line in the body passageway. These known stents areinappropriate for use in a bifurcated body passageway (e.g. a body passagewaycomprising a parent passageway that splits into a pair of passageways).Further, these stents arc inappropriate for use in a body passageway having sidebranches since: (i) accurate placement of the stent substantially increases therisk to the patient, (ii) the risk of passageway closure in the side: branches isincreased, and (iii) the side branches will be substantially inaccessible.Indeed the Physician Guide published in support of the P&lmaz-Schatzstent states on page 32 (the contents of which are hereby incorporated byreference):... no attempt should be made following placement of aPALMAZ-SCHATZ stent to access the side branch with a guidewire or a balloon, as such attempts may result in additionaldamage to the target vessel or the stent. Attempts to treatobstructed side branches within stented segments can result inballoon entrapment, necessitating emergency bypass surgery."Thus, when installed, the Balmaz-Schatz stent admittedly shields side branchesemanating from the target area of the body passageway effectively permanently.This can be problematic since the only way to treat blockage or other problemsassociated with the side branches Is; to perform the type of suigeiy whichinstallation of the stent was intended to avoid.This contraindication for conventional mono-tubular! stents iscorroborated by a number of investigators. See, for example, the following:1. Interventional Cardiovascular Medicine: Principles] andPractice (1994); Publisher: Churchill Livingstone Iqc.;pages 221-223 (Ohman et al.), 487-488 (Labinaz et al.),667-668 (Bashore et al.) and 897 (Bailey et al.),including references cited therein;2. Gianturco-Roubin Flex-Stem™ Coronary Scent:Physician's Guide; page 2, Paragraph 3 underWARNINGS;3. Circulation, Vol. 83, No. 1, January 1991 (Schatz etal.); entitled "Clinical Experience With the Palmaz-Schatz Coronary Stent"; pages 148-161 at page 149; and4. American Heart Journal, Vol. 127, No. 2, February1994 (Eeckhout et al.); entitled "Complications andfollow-up after intracoronary scenting: Critical analysisof a 6-year single-center experience"; pages 262-272 atpage 263,the contents of each of which are hereby incorporated by reference.'Further, some investigators have attempted to install individual stentsin each branch of the bifurcated body passageway. However, this approach isfraught with at least two significant problems. First, implantation of threeindividual stents, together with the expansive forces generated uponimplantation results in subjecting the central walls of the bifurcated bodypassageway to undue stress which may lead to post-procedural complications.Second, since the central walls of the bifurcated body passageway are notIsupported by the individual stents, this area of the passageway is leftsubstantially unprotected and susceptible to blockage.One particular problem area with boated body passage is theoccurrence of bifurcation lesions within the coronary circulation. General,ythese legions may be classified as follows:TypeChara^terjfffrciPrcbianch stenosis not involving the ostium ofthe side branch;B Postbranch stenosis of the parent | vessel notinvolving the origin of the side branch;C Stenosis encompassing the side branch but notinvolving the ostium;D Stenosis inrolviqg the parent vessel and ostium ofthe side branch;E Stenosis iinvolving the ostium of the side branchonly; andStenosis discretely involving the parent vesselarid ostium of the side branch.See Atlas of Interventional Cardiology (Pbpma et al.), 1994, pages 77-79 thecontents of which are hereby incorporated by reference. The prince ofbifurcation lesions is predictive of merged procedural complications Eludingacute vessel closure.Detailed classification of other bifurcated body passageways is relativelyundeveloped given the lack of non-surgical treatment approaches.United States patent 4,994,071 (MacGregor) discloses a bifurcating stentapparatus. The particular design incorporates a series of generally paralleloriented loops interconnected by a sequence of "half-birch" connections. Thelattice structure of the illustrated stent is constructed of wire. The) use of suchwire is important to obtain the loop structure of the illustrated design. The useof a wire loop construction is disadvantageous since it is complicated tomanufacture and the resulting stent is subject to expansion variability (e.g.variable post-expansion distortion and the like).United States patents 3,993,078 (Bergentz et al.) and! 5,342,387(Summers) also disclose and illustrate a bifurcated stent design constructed ofwire. These designs suffer from the same disadvantages as the design describediin the previous paragraph.It would be desirable to have a reliable, expandable bifurcated stentsince this would be useful in treating aneurysms, blockages and other ailments.It would be further desirable to have a practical method for producing such astent. It would also be desirable if such a stem was relatively easy'to install.DISCLOSURE OF THE INVENTION]It is an object of the present invention to provide a novel lexpandablebifurcated stem which obviates or mitigates at least one of the above--mentioneddisadvantages of the prior art.It is another object of the present invention to provide a novel methodfor the manufacture of an expandable bifurcated stent. jIt is another object of the present invention to provide a noivel methodfor implanting an expandable bifurcated stent.Accordingly, in one of its aspects, the present invention provides an.expandable bifurcated stent comprising a proximal end and a distal end incommunication with one another, the proximal end comprising!a primarypassageway and the distal end compris ing a pair of secondary passageways, thestent being expandable from a first, contracted position to a second, expandediposition upon the application of a radially outward force exerted on the stent,ieach of the primary passage^ and ^ ^constructed of a tubular wail having a porous sur&ce 'In another of its aspects. the present i^on providK < m5thod fofproduction of a Create* stent comprising festtpof conn£ctmg . ^ ^- » a Mond SKm sectio, rirjt sttM ^ ^ a[, ^ ^section.In yet another of its aspects, tbe present invention provides j method forproduction of a bifurcated stem comprising the steps of:0) connecting a fa, stent section to a second stent section toprovide a connection portion;(ii) provide an opening in the connection portion;(iii) connecting a third stent section to the connection portion.In yet another of its aspects, the present invention provides a method forproduction of a bifurcated stent comprising the steps of: .passing a first stent section having a first opening disposii along alength thereof through a second stent section having a second opening disposedalong a length thereof, the fl* stent section having a diameter less than adiameter of the second stent section;passing a leading end of the first stent section through the secondopening of the second stent section; andsubstantially aligning the first opening and the second opening withrespect to one another.In yet another of its aspects, the present invention provides a method fordelivery to a target body passageway of an expandable bifurcated stentcomprising a proximal end and a distal end in communication with one! anotherthe proximal end comprising a primary passageway and the diktal endcomprising a pair of secondary passageways, the stent being expandable froma first, contracted position to a second, expanded position upon the applicationof a radially out**rd force exerted on the stent, each of the primary passage^iand the secondary passageway being constructed of a tubular wall having aporous surface, the method comprising the steps of:disposing the stent in the first, contracted position on a catheter;iinserting the stent and catheter within the target body passageway bycatheterization of the target body passageway;exerting a radially outward expansive force on the stent such that thestent assumes the second, expanded position and is uiged against thJ target bodypassageway.Thus, an aspect of the present invention relates to the provision of anexpandable bifurcated stent constructed of a tubular wall having a poroussurface. As used throughout this specification, the term "tubular wall", whenused in relation to a stent, is intended to mean a substantially cylindrical tubeiwhich as been subjected to an etching (e.g. by laser, chemical or other suitablemeans) or similar technique to remove pre-selected portions of the cylindricaltube thereby providing a porous surfece on the tube - this is distinct from a stentconstructed of wire bent to a selected shape / design. To the knowledge of theiApplicant's, an expandable bifurcated stent having such a tubular wall hasheretofore been unknown. ,As used throughout this specification, the term "bifurcated stent" isintended to have a broad meaning and encompasses any stent having a primarypassageway to which is connected at least two secondary passageways. Thus,trifiircaied stents are encompassed herein. Further, one of the] secondarypassageways can be a continuation of the primary passageway with the resultthat the other secondary passageway is essentially a side branch to the primarypassageway.The Applicant's have also discovered that various repeatingjpatterns inthe porous surface of the tubular wall are particularly advantageous, i Generally,the repealing pattern is a polygon having a pair of side walls substantiallyparallel to the longitndinal axis of the stent passageway in question, a firstconcave-shaped wall and a second convex-shaped wall connecting the sidewalls. The various repeating patterns which are useful in the context of thepresent invention are disclosed in the following copending patent Applicationsfiled in the name of the assignee of the present invention:iiCanadian patent application number 2,134,997 (filed November 3,1994);Canadian patent application number 2,171,047 (filed March 5, 1996);Canadian patent application number 2,175,722 (filed May 3, 1996);Canadian patent application number 2,185,740 (filed September 17,1996); 1International patent application PCT / CA97 / 00151 (filed Mar&i 5,1997);and!International patent application PCT / CA97 / 00152 (filed March 5,1997);the contents of each of which are hereby incorporated by reference (hereinaftercollectively referred to as the "Divysio patent applications").The present bifurcated stent may be constructed from any suitablestarting material. Preferably, the starting material is a thin tube of a metal oralloy (non-limiting examples include stainless steel, titanium, tantalum, nitinol,Elgiloy, NP35N and mixtures thereof) which would then have sections thereofIcut or etched out to leave a repeating pattern, inter alia such as one |or more ofithose disclosed in the Divysio patent applications.The stent of the present invention may further comprise a coatingmaterial thereon. The coating material may be disposed continuously ordiscontinuously on the surface of the stent. Further, the coating may bedisposed on the interior and / or the exterior surface(s) of the stem. The coatingmaterial may be one or more of a biologically inert material (e.g. toireduce thethrombogenicity of the stent), a medicinal composition which leaches into thewall of the body passageway after implantation (e.g. to provide anticoagulantaction, to deliver a pharmaceutical to the body passageway and the like) and thelike.iThe stent is preferably provided with a biocompatible coating, in orderio minimize adverse interaction with the walls of the body vessel imd / or withthe liquid, usually blood, flowing through the vessel. The coating is preferablya polymeric material, which is generally provided by applying to] the stent aisolution or dispersion of preformed polymer in a solvent and removing thesolvent. Non-polymeric coating material may alternatively be used. Suitablecoating materials, for instance polymers, may be polytetraflouroediylene orsilicone rubbers, or polyurethanes which are known to be biocompatible.Preferably, however, the polymer has zwinerionic pendant groups, generally!ammonium phosphate ester groups, for instance phosphoryl cholinie groups oranalogues thereof. Examples of suitable polymers are described in publishedInternational patent applications WO-A-93 / 16479 and WO-X-93 / 15775.Polymers described in those specifications are hemo-compatiblejas well asgenerally biocompatible and, in addition, are lubricious. When a biocompatibleicoating is used, It is important to ensure that the surfaces of the stent arecompletely coated in order to minimize unfavourable interactions, for instanceiwith blood, which might lead to thrombosis. 1IThis good coating can be achieved by suitable selection of coatingconditions, such as coating solution viscosity, coating technique and / or solventremoval step.BRIEF DESCRIPTION OF THE DRAWINGEmbodiments of the present invention will be described with referenceto the accompanying drawings wherein like numerals designate like parts andin which:Figure 1 illustrates a side elevation of a bifurcated stent in accordancewith the present invention;Figures 2-4 illustrate a first embodiment of a method for production ofa bifurcated stent;Figure 5 illustrates a second embodiment of a method for production ofa bifurcated stent;Figures 6a and 6b illustrate a post-treatment of a bifurcated stent whichhas been produced according to the methods illustrated in Figures 2-5;!Figures 7 and 8 illustrate a third embodiment of a method for productionof a bifurcated stent;Figure 9 illustrates a post-treated bifurcated stent which; has beeniproduced according to the method illustrated in Figures 7 and 8;Figures 10 and 11 illustrate a fourth embodiment of a method forproduction of a bifurcated stent;Figure 12 illustrates a cross-section of a bifurcated body passagewayinto which the a bifurcated stent produced according to the present method ofimanufacture is being delivered;jFigure 13 illustrates a cross-section of a bifurcated body passageway inwhich the bifurcated stent is positioned in a first, contracted position;Figure 14 illustrates a cross-section of a bifurcated body passageway inwhich the bifurcated stent is positioned in a second, expanded position;iFigures 15 and 16 illustrate a side elevation of another bifurcated stentin accordance with the present invention;iFigures 17-22 illustrate various preferred features of the bifurcated stentiillustrated in Figures 15 and 16.BFST MODE FOR CARRYING OUT THF. INVENTION jWith reference to Figure 1, there is illustrated a stent 10. j Stent 10comprises a proximal end 15 and a distal end 20. Proximal end 15 comprisesa primary passageway 25. Distal end 20 comprises a pair of secondarypassageways 30,35. Secondary passageways 30,35 are connected to primarypassageway 25 at an intersection point 40. !As will be apparent to those of skill in the art, stent 10 incorporates theporous surface design illustrated in copending Canadian patent applicationnumber 2,134,944, referred to above. As discussed above, this design may beivaried to incorporate other designs such as those disclosed in the other Divysiopatent applications.iIWith reference to Figures 2-4, an embodiment of the present!method forproduction of a bifurcated stent is illustrated. For ease of illustration, theporous surface of the tubular wall of the stent is not illustrated.As illustrated, a first stent section 45 comprises a cylindrical {tube havinga bevelled cut 50 made adjacent one end of the cylindrical tube. Tljrose of skillin the art will recognize that bevelled cut 50 may be incorporated into first stentsection 45 during or after the production of first stent section 45. Specifically,it is possible to produce first stent section 45 having a pre-selected porousdesign which includes bevelled cut 50 via a computer programmable, highprecision laser etching technique. Alternatively, it is possible to use anotheretching technique to produce first stent section 45 without bevelled cut 50 andthereafter use a precision jig or other means to cut first stent section 45 toIproduce bevelled cut 50.Similarly, a second stent section 55 is provided and includes radial cuts56,57 and a longitudinal cut 58. Radial cuts 56,57 and longitudinal cuts 58 maybe produced in second stent section 55 in the manner discussed in the previousparagraph with respect to the production of bevelled cut 50 in first stent section45. Thereafter, a flap portion 51 of first stent section 45 is folded away frombevelled cut 50. Similarly, a pair of flap 52,53 are folded;away fromlongitudinal cut 58 to expose an opening 54. First stent section 45 is thenlowered to cover opening 54 of second stent section 55. Flaps 52,53 are foldedito overlap a portion of first stent section 45. Flap 51 is folded to overlap aportion of second stent section 55. With reference to Figure 4, it is particularlypreferred to adapt the geometry of flaps 52,53 of second stent section 55 suchthat various of the struts disposed in flaps 52,53 overlap with or are juxtaposed(in plan view) along at least a portion of the length thereof with the struts onfirst stent section 45 (this is illustrated in more detail hereihbelow withreference to Figure 16). Preferably, the degree of such overlap or juxtapositionis sufficient to:(i) facilitate affixing the flaps 52,53 of second stent section55 to first stent section 45; j(ii) achieve uniform expansion of the stent junction withoutioccurrence of substantial distortion; and(iii) avoid the occurrence of "stent trap" or "stent jail"i(usually the result of cracking, buckling or otherdistortion at the junction of a deployed bifurcated stentmaking difficult or impossible to deliver a further stentthrough the stent).iiAt this point, the flaps may be secured to the respective stent sectionsby any suitable means such as spot welding (e.g. by a laser or other suitablemeans), loops, clips and the like. The preferred method of affixing jthe flaps tothe respective stent section is to spot weld them.A particular advantage of the process illustrated in Figures 2-4 is thatintersection point 40 (Figure 1 - overlapping flaps not illustrated for clarity) ofthe resulting stent is reinforced by virtue of disposition of the flaps overlappinga portion of the respective stent sections. jAs will be apparent to those of skill in the art, in certain circumstances,it may be possible and even desirable to reduce the size of or even eliminateflap 51. Further, in certain circumstances, it may be possible or ever desirableto trim one or both of flaps 52,53 prior to connection of first stent section 45to second stent section 55.With reference to Figure 5, there is illustrated another embodiment ofthe present method for manufacture of a bifurcated stent. In this embodiment,flap 51 (Figures 2 and 3) is simply cut away from first stent section 45a.Further, an oval opening 54a is cut into second stent section 55a (iie. there areno flaps affixed to second stent section 55a). Stent section 45a is then loweredon and connected to second stent section 55a. First stent section 45a andsecond stent section 55a may be connected to another in the manner describedhereinabove with reference to Figure 2-4.IWith reference to Figure 6a, there is illustrated the stent produced by themethods illustrated in Figures 2-5. During production of the istent, it isidesirable to minimize the angle between first stent section 45 and second stentisection 55. Even with this effort, it is preferred that the adjacent termini of firstistent section 45 and section stent section 55 are subjected to application ofgentle squeezing or other sufficient force in the direction of arrows A tofacilitate catheterization of the stent. The result of such postjproductiontreatment of the stent is illustrated in Figure 6b.iWith reference to Figures 7 and 8, there is illustrated yet anotherjembodiment of the present method for manufacture of a bifurcated stent. In thisembodiment, a pair of first stent sections 45b are secured or affixed to oneanother. Thereafter, an apex portion 46b of the resulting construction isremoved exposing an opening 54b. A second stent section 55b is thenconnected to opening 54b provided by the combination of first stent sections45b. The manner of securing second stent section 55b to the periphery ofiopening 54b created by first stent sections 45b is not particularly restricted andmay be effected as discussed hereinabove. As will be appreciated by those ofiskill in the art, it is possible and, in certain circumstances, desirable, to haveone or more flaps on one or move of first stent sections 45b and second stentsection 55b. Such flaps would be used in the manner discussed hereinabove inrespect of Figures 2-4 to overlap a portion of the opposite stent section.With reference to Figure 9, there is illustrated the stent producedaccording to the method illustrated in Figures 7 and 8 after post-treatment in themanner discussed above in respect of Figures 6a and 6b. That is, first stentsections 45b are subjected to application of gentle squeezing or other sufficientforce in die direction of arrows B to facilitate catheterization of the! stentWith reference to Figures 10 and 11, there is illustrated lyet anotherembodiment of the present method for manufacture of a bifurcated stent. In thisIembodiment, a first stent section 45c is provided with an opening 54c. Asecond stent section 55c is provided with an opening 56c. Second stent section55c has a diameter slightly less than that of first stent section 45c. ' Theidifference in diameter between first stent section 45c and second stent sectioni55c is sufficient to enable coaxial movement of the stent sections with respectto one another with causing damage to either stent section.As illustrated by arrow C in Figure 10, the end of second stent sectioni55c is coaxially fed into an end of first stent section 45c. Once the leading endiof second stem section 55c reaches opening 54c of first stent section 45c, it ispulled through opening 54c as illustrated by arrow D in Figure 10. Secondistent section 55c is pulled through opening 54c until opening 56c is aligned withopening 54c - this is illustrated by dashed oval E in Figure 11.When practising the method illustrated in Figures 10 and 11, care shouldbe taken to design openings 54c and 56c so that they are in alignment when thetrailing end of second stem section 55c is flush with the trailing end of firststent section 45c. Further, region F (Figure 11) of the resulting bifurcated stentis "double reinforced" since it contains a coaxial disposition of first stent sectioni45c and second stent section 55c. Accordingly, it is possible and, in;some caseseven desirable, to modify the design of the respective stent sections in thisiregion so that the overall expansion and relative flexibility / rigidity 'of the stentiin this region is commensurate with that of the remaining portion of the stenti(i.e. the secondary passageways which branch off from region F in Figure 11).iWhile the embodiment illustrated in Figures 10 and 11 illustrates theresultant bifurcated stent having a coaxial, overlapping arrangement of stentsections flush at one end, it will be appreciated by those of skill in the art thatthe length of first stent section 45c or second stem section 55c may be shortenedthereby minimizing the size of region F in Figure 11.iWith reference to Figures 12-14 , there is illustrated a bifurcated bodypassageway 150 comprised of a proximal passageway 155 and a pair of distaljpassageways 160,165. As illustrated, bifurcated body passageway 150comprises a Type "D" Bifurcation lesion having characteristicblockages 170,175,180. !Stent 10 is delivered to bifurcated body passageway 150 in the followingmanner. Initially, a pair of guidewires 185,190 are inserted into proximalipassageway 155 such that guidewiie 185 enters distal passageway 160 andguidewire 190 enters distal passageway 165. The manner by which theguidewires are inserted is conventional and within the purview cjf a personskilled in the art.As illustrated, stent 10 is positioned in association with a pair oficatheters 195,200 (for clarity, the interior of stent 10 is not shown).Catheter 195 has associated with it a balloon 205. Catheter 200 has! associatediwith it a balloon 210. Balloons 205,210 substantially fill primarypassageway 25 of stent 10. Balloon 205 substantially fills: secondarypassageway 30 of stent 10. Balloon 210 substantially fills j secondarypassageway 35 of stent 10.iThe stent / catheter / balloon combination is delivered through proximalpassageway 155 with the aid of guidewires 185,190. ' As theistent / catheter / balloon combination approaches distal passageways 160,165,predisposition of guidewires 185,190 serves to separate secondary passagewaysi30,35 to be disposed in distal passageways 160,165, respectively.! Thus, asillustrated in Figure 13, stent 10 is positioned in place.IOnce stent 10 is in position, balloons 205,210 are expanded resulting inimplantation of stent 10 in the corresponding interior surfaces of proximalipassageway 155 and distal passageways 160,165. Upon implantation of stent10, balloons 205,210 are collapsed. Thereafter, catheters 195,200 andguidewires 185,190 have been removed leaving the implanted stent 10 showntin Figure 14. As illustrated in Figure 14, blockages 170,175,180! are bulgedL . ,radially outwardly in combination with the appropriate portions ct proximalpassageway 155 and distal passageways 160,165 resulting in a reduction in theoverall blockage in bifurcated body passage 150.It will be apparent to those of skill in the art that implantation of stent 10can be accomplished by various other means. For example, it is contemplatedithat it is possible to substitute the pair of catheter / balloon combinationsillustrated in Figures 12 and 13 with a single, bifurcated catheter / balloon designiwhich mimics the design of the stent. Thus, in this modification, the balloonand guidewiie would be design to mimic the bifurcated design of the stent. Asifurther alternative, it is contemplated that the stent can be made of a suitablematerial which will expand when bifurcated body passageway 150 is flushedwith a liquid having an elevated temperature (e.g. 150aF-160°F)|. Further,stent 10 can be designed to expand upon the application of mechanical forcesiother than those applied by a balloon / catheter. Still further, stent 10 can beidesigned self-expanding (e.g. by constructing stent from material such as nitinoland the like) to be implanted as described above. In this embodiment, theradially outward force exerted on the stent would be generated within the stentitself. JWith reference to Figures 15-22, there is illustrated another preferredibifurcated stent in accordance wiih the present invention. As will be apparentto those of skill in the art, the stent illustrated in Figures 15-22 shares many ofthe features of stent 10 illustrated in Figure 1.Thus, with reference to Figures 15 and 16, there is illustrated a stent100. Figure 15 is a side elevation of stent 100 without the porbus surfaceillustrated (for clarity). Figure 16 is a side elevation of an enlarged portion ofstent 100 with the porous surface illustrated. Stent 100 comprised a proximalend 102 and a distal end 104. Proximal end 102 comprises! a primarypassageway 103. Distal end 104 comprises a pair of secondary passageways105,106. Secondary passageways 105,106 are connected to primarypassageway 103 at an intersection point 107 - the nature of intersection pointi107 will be further discussed hereinbelow. It is intersection point 107 whichdistinguishes stent 100 in Figure 16 from stent 10 in Figure 1. iAs will be apparent to those of skill in the art, stent 100 incorporates theporous surface design illustrated in copending Canadian patent' applicationnumber 2,134,944, referred to above. As discussed above, this design may bevaried to incorporate other designs such as those disclosed in the other Divysiopatent applications.With reference to Figures 17-19, manufacture of stent 100 will bediscussed. Generally, the manufacture of stem 100 is similar to themanufacture of stent 10 illustrated in Figures 1-4 and discussed hereinabove.The principle difference in the manufacture of stent 100 is the use of a modifiedifirst stent section 108. 'iFirst stent section 108 is constructed from a substantially cylindrical tube109. A porous surface 110 is disposed on a major portion of cylindrical tube109. A first connection tab 111 and a second connection tab 1|32 are alsodisposed on cylindrical tube 109. As discussed hereinabove, it is; possible toproduce first section 108 comprising porous 110, first connection tab 111 andsecond connection tab 112 using computer programmable, high precision laseretching techniques or by other etching techniques in combination with precisionjig techniques. This results in an end of porous surface 110 comprising firstconnection tab 111, second connection tab 112 and a bevelled edge 113. Theproduct of the cutting techniques is illustrated in Figure 18. ]Figure 19 isan enlarged perspective view of a portion of first connection tab 111 (secondconnection tab 112 is preferably the same). As illustrated, first connection tab111 comprises a stem 114 and a head 115. Preferably, stem 114 and / or head115 are curved to have a shape complementary to the outer surface of thesecond section to which first stent section 108 is connected (discussed in moredetailed hereinbelow). Stem 114 and head 115 comprise a plurality lof slots 116idisposed therein. Slots 116 may be disposed in stem 114 and head 115 by theuse of a computer programmable, high precision laser as described above.iPreferably, slots 116 are disposed throughout the thickness of stem 114 andhead 115. Slots 116 may be may have a straight or tapered cross-section.Preferably, slots 116 have a thickness in the range of from about 0.0015 toabout 0.004 inches. Head 115 further comprises solid (i.e., slot-free or non-porous) regions 117.Thus, in the embodiment illustrated in Figure 19, slots 116 serve tofrom a porous surface in first connection tab 111 (second connection tab 112 ispreferably the same). While it is preferred to have such a porous surfacedisposed in the connection tabs, the precise nature of the porosity is notiparticularly restricted. The provision of a porous surface, particularly at head115, facilitates expansion of the connection tab while minimizing or avoidingthe occurrence of cracking or distortion. |iAfter the production of first stent section 108, first connection tab 111and second connection tab 112 are bent or otherwise moved to be substantiallyicollinear with the periphery of bevelled edge 113 (i.e., as illustrated in Figure118). At this point, first stent section 108 may be connected to another stentsection of a design similar to second stent section 55 discussed hereinabove withireference to Figures 2-4 - see intersection point 107 in Figure 16. In thisembodiment, as in the embodiments illustrated in Figures 2-4, it is preferred toiadapt the geometry of flaps 52,53 of second stent section 55 such that variousof the struts disposed in flaps 52,53 overlap along at a portion of the lengththereof with the struts on first stent section 108. See, for example, regions Giand H in Figure 16 which illustrates an embodiment of such partial joverlap andjuxtaposition (in plan view). Of Fust connection tab 111 and secondiconnection tab 112 may be secured to the second stent section as describedabove. Specifically, it is particularly preferred to connect solid! (i.e., non-iporous) regions to the section stent portion. |The benefits accruing from the use of first stent section! 108 in theproduction a bifurcated stent include:I1. The provision of at least one solid (i.e., non-porous)iregion in the connection tabs facilitates attachment of therespect stent sections to one another (e.g. laser welidingiis facilitated significantly); ;2. The provision of a porous surface in at least a portion ofthe connection tabs facilitates bending thereof forconnection of the respective stent sections; and !3. The provision of slots 116, particularly in secondconnection tab 112 (see Figure 15), allows the slots toiifunction as a solid state valve at the "crotch" of j theIbifurcated stent thereby providing sealed, reinforcementof the bifurcated stent in this crucial region - this isillustrated in Figure 20 which depicts tapered openingsifor slots 116 and the apex of the bend in stem 114.Figure 21 illustrates an alternate embodiment of the embodimentillustrated in Figures 15-20. Specifically, in Figure 21, second stentj section 55,iotherwise the same as that described hereinabove with reference to Figures 1-4,is adapted to include a landing 119 for receiving a solid (i.e. non-slot or non-porous) connection tab 120. Landing 119 may be connected to connection tab120 as described hereinabove.With reference to Figure 22, there is illustrated a variant to theembodiment illustrated in Figure 21. Specifically, in Figure 22, a1 connectiontab 121 having the entire surface thereof slotted and otherwise porous isconnected to landing 119. ;While this invention has been described with reference to illustrativeiembodiments, this description is not intended to be construed in a limitingsense. Various modifications of the illustrative embodiments, as well as otherembodiments of the invention, will be apparent to persons skillejd in the artiupon reference to this description. For example, while first connection tab 111!and second connection tab 112 have been illustrated as being attached to firstistent portion 108, it is possible to have these tabs integral with second stentiportion 55. Alternatively, the connection tabs do not have to integral witheither of the stent portions and, instead, can be custom-designed, independenticonnection tabs which are affixed to both stent portions. Still further, it ispossible for the connection tabs (integral or independent) to have a differentithickness than either of the stent sections. It is therefore contemplated that theappended claims will cover any such modifications or embodiments.
Claims
1. An expandable bifurcated stent having a longitudinal axis, the stent comprising a proximal end and a distal end in communication with one another, the proximal end comprising a primary passageway and the distal end comprising a pair of secondary passageways, each secondary passageway in communication with the primary passageway at a first intersection, the stent being expandable from a first, contracted position to a second, expanded position upon the application of a radially outward force exerted on the stent, the intersection comprising a circumferential region consisting of: (i) points of connection between the primary passageway and the secondary passageway, and (ii) an area of contacting overlap between the primary passageway and the secondary passageway, the primary passageway and the contacting area in the secondary passageway being moveable with respect to one another in a direction substantially parallel to the longitudinal axis.
2. The bifurcated stent defined in claim 1, wherein the area of overlap is defined by a first area on the primary passageway and a second area on the secondary passageway.
3. The bifurcated stent defined in claim 2, wherein the first area is disposed within the second area.
4. The bifurcated stent defined in claim 2, wherein first area is defined by a substantially elongate tab.
5. The bifurcated stent defined in claim 4, wherein the substantially elongate tab has a head and a body, the head being radially wider than the body.
6. The bifurcated stent defined in claim 1, comprising at least two areas of overlap.
7. The bifurcated stent defined in claim 1, comprising two areas of overlap.
8. The bifurcated stent defined in claim 7, wherein the two areas of overlap are substantially diametrically opposed to one another in the circumferential region.
9. The bifurcated stent defined in claim 1, wherein the pair of secondary passageways are integrally connected to one another by a segment.
10. The bifurcated stent defined in claim 1, wherein the stent comprises a first stent section connected to a second stent section.
11. A method for production of a bifurcated stent comprising the steps: cutting a portion of a circumference of a first stent section, the uncut portion of the circumference defining a connection tab; translating opposed ends of the first stent section toward one another to define a first opening along the length of the first stent section; and connecting a second stent section to first stent section at the opening.
12. The method defined in claim 11, wherein the translating step comprises bending the connection tab.
13. The method defined in claim 11, wherein the cutting step comprises a non-linear radial cut to define a serrated first opening.
14. The method defined in claim 13, wherein the non-linear radial cut is a substantially sinusoidal radial cut.
15. The method defined in claim 13, wherein the non-linear cut is a substantially undulating radial cut.
16. The method defined in claim 11, wherein the connecting step comprises positioning the first stent section and the second section stent section to define an area of overlap therebetween.
17. The method defined in claim 16, wherein the connecting step comprises selectively connecting the first stent section to the second stent section in the area of overlap.
18. The method defined in claim 16, wherein said positioning comprises disposing the second stent section within the first stent section to define the area of overlap.
19. The method defined in claim 11, wherein the connecting step comprises welding the first stent section to the second stent section.
